禮來公司
IT ˙ BIT ˙ US5324571083
€979.80 ↑43.70 (4.67%)
2026-06-04
分享價格
SecurityIT:1LLY / Eli Lilly and Company
InstitutionLipe & Dalton
Latest Disclosed Ownership13 shares
Latest Disclosed Value $ 12
Lipe & Dalton ownership in 1LLY / Eli Lilly and Company

On April 29, 2026 - Lipe & Dalton filed a 13F-HR form disclosing ownership of 13 shares of Eli Lilly and Company (IT:1LLY) valued at $10,068 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 26, 2026 disclosing 13 shares of Eli Lilly and Company. The current value of the position is $12,737 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-29 2026-03-31 13F Lilly Eli cs 532457108 13 0 0.00 0 0.0063
2026-01-26 2025-12-31 13F Lilly Eli cs 532457108 13 13 0 0.0069
2025-02-03 2024-12-31 13F Lilly Eli cs 532457108 0 -45 -100.00 0 0.0000
2024-11-04 2024-09-30 13F Lilly Eli cs 532457108 45 -11 -19.64 0 0.0202
2024-08-02 2024-06-30 13F Lilly Eli cs 532457108 56 0 0.00 0 0.0274
2024-05-07 2024-03-31 13F Lilly Eli cs 532457108 56 11 24.44 0 0.0227
2024-01-30 2023-12-31 13F Lilly Eli cs 532457108 45 45 0 0.0141
2021-04-30 2021-03-31 13F Lilly Eli CS 532457108 0 -100 -100.00 0 -100.00
2021-01-29 2020-12-31 13F Lilly Eli CS 532457108 100 0 0.00 17 13.33 0.0105
2020-10-30 2020-09-30 13F Lilly Eli CS 532457108 100 0 0.00 15 -6.25 0.0104
2020-08-07 2020-06-30 13F Lilly Eli cs 532457108 100 0 0.00 16 14.29 0.0116
2020-05-01 2020-03-31 13F Lilly Eli cs 532457108 100 0 0.00 14 7.69 0.0118
2020-01-21 2019-12-31 13F Lilly Eli cs 532457108 100 0 0.00 13 18.18 0.0086
2019-11-07 2019-09-30 13F Lilly Eli cs 532457108 100 -10 -9.09 11 -8.33 0.0080
2019-07-24 2019-06-30 13F Lilly Eli cs 532457108 110 0 0.00 12 -14.29 0.0086
2019-04-30 2019-03-31 13F Lilly Eli cs 532457108 110 110 14 0.0103
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.